What was the value of Learningrx's deferred income taxes categorized as other noncurrent assets in 2023?
Learningrx Franchise · 2025 FDDAnswer from 2025 FDD Document
planned scope and timing of the audit, significant audit findings, and certain internal control related matters that we identified during the audit.
Springfield, Missouri
January 3, 2024
LearningRx Franchise Corporation Balance Sheets As of September 30, 2023 and 2022
Assets
| 2023 | 2022 | |
|---|---|---|
| Current Assets | ||
| Cash and cash equivalents Accounts receivable, net of allowance of | $ 551,641 | $ 534,941 |
| $23,629 in 2023 and $46,075 in 2022 | 243,535 | 246,972 |
| Prepaid expenses | 1,635 | |
| Deferred income tax asset | 19,663 | 24,158 |
| Total Current Assets | 814,839 | 807,706 |
| Property and Equipment |
Source: Item 23 — RECEIPT (FDD pages 54–209)
What This Means (2025 FDD)
According to Learningrx's 2025 Franchise Disclosure Document, the value of deferred income taxes categorized as other noncurrent assets was $155,827 in 2023. This figure represents the company's deferred tax assets, which are future tax benefits that will be realized due to temporary differences between the book value of assets and liabilities and their tax bases. These deferred tax assets are classified as 'Other Noncurrent Assets' on Learningrx's balance sheet.
For a prospective Learningrx franchisee, understanding the company's deferred tax position can provide insights into its financial health and future tax obligations. Deferred tax assets typically arise from situations such as net operating loss carryforwards or differences in depreciation methods used for accounting and tax purposes. The presence of deferred tax assets suggests that Learningrx anticipates future taxable income against which these assets can be utilized, potentially reducing future tax liabilities.
It's important to note that the realization of deferred tax assets depends on Learningrx's ability to generate sufficient taxable income in the future. Changes in tax laws or the company's financial performance could impact the ultimate value of these assets. Franchisees should consider these factors when evaluating Learningrx's financial statements and assessing the overall investment opportunity. Reviewing the notes to the financial statements for more details on the nature and assumptions underlying these deferred tax assets is also advisable.
In addition to deferred income taxes, Learningrx also lists 'Right-of-use assets' under 'Other Noncurrent Assets,' valued at $220,053 in 2023. The 'Net Other Noncurrent Assets' totaled $375,880 in 2023. These figures, along with the deferred income taxes, provide a comprehensive view of Learningrx's long-term asset position.